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Abstract: The mode of action of a huge amount of agents on biological systems is still unknown. One example where 
more questions than answers exist is covered by the term electromagnetic fields (EMF). Use of wireless communication, 
e.g. mobile phones, has been escalated in the last few years. Due to this fact, a lot of discussions dealt with health conse-
quences of EMF emitted by these devices and led to an increased investigation of their effects to biological systems, 
mainly by using traditional methods. Omics technologies have the advantage to contain methods for investigations on 
DNA-, RNA- and protein level as well as changes in the metabolism.  
This literature survey is an overview of the available scientific publications regarding biological and health effects of 
EMF and the application of new high-throughput technologies. The aim of the study was to analyse the amount and the 
distribution of these technologies and to evaluate their relevance to the risk analysis of EMF. At present, only transcrip-
tomics is able to analyse almost all of the specific molecules. In comparison to ionising radiation, fewer articles dealt with 
health effects of EMF. Interestingly, most of the EMF articles came from European institutions. 
Although omics techniques allow exact and simultaneous examinations of thousands of genes, proteins and metabolites in 
high-throughput technologies, it will be an absolute prerequisite to use standardised protocols and to independently vali-
date the results for comparability and eventually for sound standing statements concerning possible effects of agents like 
EMF on biological systems.  
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INTRODUCTION 
  The current nomenclature of omics sciences includes 
genomics for DNA variations, transcriptomics for messenger 
RNA, proteomics for peptides and proteins, and metabolom-
ics for intermediate products of metabolism [1, 2]. Techno-
logical breakthroughs allow simultaneous examination of 
thousands of genes, transcripts, proteins, and metabolites 
with high-throughput techniques and analytical tools to ex-
tract information. Hypothesis-driven research and discovery-
driven research (through omic methodologies) are comple-
mentary and synergistic. Modern screening technologies 
speed up the discovery process and give broader insight into 
biochemical events that follow the exposure to harmful 
agents e.g. chemical substances, ionising radiation or elec-
tromagnetic fields.  
  High-throughput transcriptomic and proteomic technolo-
gies have been already adopted to study the expression of 
certain genes and proteins in response to ionising radiation 
or electromagnetic fields. 
  The aim of the work is to critically compare the amount 
of distribution of these omics technologies in the investiga- 
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tions of biological influences of ionising radiation and non-
ionising electromagnetic fields (EMF). Therefore, an over-
view was created containing the used omics methods, their 
geographical and chronological distribution and the investi-
gated biological endpoints. 
  For several decades the effects of EMF on the health of 
humans have been investigated by using traditional methods, 
and despite intensive research there is still a controversial 
scientific discussion regarding potential effects in the range 
below and near existing safety limits. Therefore, electro-
magnetic fields have been given an increased attention in 
this study. 
  To simplify matters, EMF are divided in low frequency 
(ELF - extremely low frequency; up to 100 kHz) and high 
frequency (RF - radiofrequency; 100 kHz - 300 GHz) fields 
in this survey. The latter contain fields of 300 MHz - 300 
GHz often defined as microwaves. In technical ways, they 
are used e.g. by TV transmitters, mobile phones, microwave 
ovens and radar systems.  
  The mode of action of low and high frequency electro-
magnetic fields on biological systems are different: whereas 
ELF-EMF mainly exert influences on the membrane and 
thus are capable to stimulate nerves and muscles [3, 4], RF-
EMF cause primarily tissue heating by absorption of electro- 
magnetic waves in polar molecules - above all - water [5, 6]. High-Throughput Omics Technologies  Current Genomics, 2009, Vol. 10, No. 2    87 
  Often ionising radiation (mainly -, X-, or UV-radiation) 
is used as positive control or as co-exposure to look for addi-
tive/synergistic effects to non-ionising EMF. Biological ef-
fects of ionising radiation are rather well-known, at least in 
comparison to low-level non-ionising radiation. Addition-
ally, a dose-response relationship is established for the acute 
effects of ionising radiation.  
  Omics technologies have already been used in the past 
few years to clarify the question whether EMF have biologi-
cal and health consequences. Diverse experimental ap-
proaches were utilised to analyse gene and protein expres-
sions in different pathways. In this respect it is important to 
prove how far the implemented experimental methods are 
comparable and to what extent they are validated by alterna-
tive methods.  
  The outcome is a recommendation in which direction a 
possible standardisation in terms of methods and analysis 
may be possible in order to ensure the comparability of the 
results and a high quality of omics studies. 
METHODS AND RESULTS 
Selection of Relevant Publications 
  To collect all relevant publications the databases Pub-
Med-Medline [7], and the EMF-Portal of the Research Cen-
tre for Bioelectromagnetic Interaction of the University Hos-
pital of the RWTH Aachen [8] were analysed. PubMed-
Medline is a service of the U.S. National Library of Medi-
cine and the National Institutes of Health. The EMF-Portal is 
a literature database providing summaries of scientific stud-
ies, and additional comprehensive information material on 
the topic “electromagnetic fields and health”.  
  First scientific reflections relating biological effects of 
EMF using omics technologies were published in 1998. On 
this account the observed period of the literature survey 
comprises the years 1998 to June 2008. 
  On the basis of specific keywords (genomics/methyla- 
tion/mutation/array, transcriptomics/expression/mRNA/array, 
proteomics/expression/protein/array, metabolomics/metabo-   
lism/array) scientific articles were selected inside the men-
tioned databases. In parallel, publications were captured in-
vestigating biological effects not only from EMF (ELF-
EMF/RF-EMF/electromagnetic field), but also from chemi-
cals and pharmaceuticals, carcinogens and ionising radiation 
(-, X-, or UV), respectively.  
  In addition to the name of the journal, date of publica-
tion, title of the scientific article, and the institute all data 
dealing with the experimental work were captured (investi-
gated biological material, kind and duration of radiation, 
used omics technologies, arrays and chips and their manu-
facturers, validation of the results via other methods as well 
as information concerning the biological effects). 
Much Less Articles Concerning RF-EMF and Omics 
Technologies Compared to other Areas  
  When using omics technologies as selection Fig. (1) 
clearly shows more activities in the areas dealing with 
chemicals and pharmaceuticals than in EMF research.  
  This is mainly due to the different number of investigated 
agents. Whereas in the EMF field only a limited number of 
frequencies were screened there are considerably more 
chemical substances under testing. In addition, activities like 
the Toxic Substances Control Act (TSCA) in the US [9] or 
Registration, Evaluation and Authorization of Chemicals 
(REACH) [10] of the EU put more attention on the effects of 
chemicals than of physical items. Not least, the much higher 
amount of money is to mention that chemical and pharma-
ceutical companies are spending for testing their products. 
 
 
 
 
 
 
 
 
 
 
 
Fig. (1). Different investigation areas and number of publications. 
The bars show the number of published scientific articles. The different colors mark applied omics technologies (dark grey – genomics, mid-
dle grey – transcriptomics, light grey – proteomics). 88    Current Genomics, 2009, Vol. 10, No. 2  Blankenburg et al. 
Relatively Few Articles Meet the Prerequisite to Deal 
with Omics Technologies 
  For the final evaluation, scientific publications concern-
ing EMF and ionising radiation were analysed only if they 
were written in English, if they were peer reviewed and if the 
used methods belong to omics technologies. Articles were 
excluded in the case when only few genes were tested (ge-
nomics), few expression data were collected (transcriptom-
ics, proteomics) or few metabolites were analysed (me-
tabolomics). This led to a sharply reduced and changed 
number of scientific articles (Fig. 2).  
  It was obvious that at the present state the promise to 
analyse almost all of the molecule species can only be met in 
the transcriptomics field. Only articles with expression 
analyses at the mRNA level by microarrays were covering a 
sufficient number of molecules and can be called to use 
high-throughput omics methods. 
Preferences for Special Manufacturers 
  Many producers offer a variety of arrays and chips that 
can be used for omics investigations. In the beginning of the 
studies often self-made arrays were used. In the experimental 
work relating to effects caused by ionising radiation (Fig. 
3A), a great diversity is seen.  
  Products of the companies Affymetrix (19%) and Clon-
tech (16%) were used in about a third of the articles. How-
 
 
 
 
 
 
 
 
 
Fig. (2). Revised number of publications. 
Different shades denote investigated radiation and EMF, respectively (dark grey – ionising radiation, middle grey – EMF). 
 
 
 
 
 
 
 
 
 
 
 
Fig. (3). Most used producers of chips and arrays. 
Different colors mark the producer of the most frequently used arrays and chips: 3A investigation of the effects of ionising radiation and 3B 
research on influences of EMF. Producers with lower participation are summarized in term “other”. High-Throughput Omics Technologies  Current Genomics, 2009, Vol. 10, No. 2    89 
ever, self-made arrays or chips (23%) or products from other 
producers (39%) were used to a greater extent. This is one 
reason why it is so difficult to compare and valuate the re-
sults from different laboratories.  
  Interestingly, differences were detected in publications 
dealing with EMF in comparison to the situation concerning 
ionising radiation. As seen in Fig. (3B) Affymetrix chips 
were used most (38%). In addition, use of Clontech products 
(12%) and arrays of the German Resource Centre for Ge-
nome Research – RZPD (9%) were described. Nevertheless, 
self-made arrays of separate labs and diverse arrays of other 
producers were used in about half of the articles. 
  However, in the course of time it seems that there exists a 
clear preference for a limited number of products from few 
manufacturers. 
Much More Articles Concerning Ionising Radiation and 
Omics Technologies Compared to EMF  
  Articles dealt with ionising radiation mainly investigated 
particle- and wave radiation (Fig. 4A).  
  Effects of wave radiation (containing -, X- und UV-
radiation) were investigated in 70% of the selected publica-
tions. Particle radiation (containing , , and neutron radia-
tion as well as HZE - high Z and high energy particle of the 
galactic cosmic radiation) was studied in 7% of all cases. In 
23% of the scientific articles the kind of radiation was not 
specified. 
  In the EMF area the most frequently published articles 
dealt with RF-EMF (65%) (Fig. 4B). In contrast only 26% of 
the articles investigated effects of ELF-EMF and 9% of other 
kind of fields (direct current, 0 Hz), respectively.  
  The use of omics technologies in the research on effects 
from both ionising radiation and EMF occurred in a rather 
moderate extent (Fig. 5).  
  Interestingly, in the first seven years the research on ef-
fects of EMF remained on a constant and very low level. 
After this period of time a short-term but significant increase 
was detected in 2006. In comparison, the research on ionis-
ing radiation showed a constant increase until 2003. A sec-
ond small maximum can be found in 2006. In 2007, the 
number of investigations from both, ionising radiation and 
EMF, fell down remarkably. Articles published in 2008 
could not be included in this diagram because data for the 
year 2008 are fragmentary and could lead to false impres-
sions. 
EMF Research with Omics Methods is Mainly Done in 
Europe 
 Fig.  (6) shows the distribution of the publications per 
continent.  
  Laboratories in America, and especially in the US, were 
very active in investigating health effects of ionising radia-
tion by omics methods. More than half of the articles were 
published by American authors. In contrast, we observed a 
nearly equal intensity of research on EMF with omics meth-
ods in America, Asia and Europe. It is remarkable that there 
is such a relatively low number of articles published by 
American authors. In addition, it is surprising that in com-
parison to other continents most of the EMF articles came 
from European institutions. 
High Diversity of Used Biological Materials 
  An enormous heterogeneity was detected with respect to 
the investigated biological materials in EMF research as well 
as in the research of ionising radiation with omics methods 
(Table 1).  
  This diversity makes it even more difficult to compare 
data from different articles and to appraise whether the de-
 
 
 
 
 
 
 
 
 
 
Fig. (4). Number of publications and the investigated radiations. 
4A contains the distribution of the publications belonging to one kind of ionising radiation (dark grey – wave radiation (, X and UV), mid-
dle grey – particle radiation (, , neutrons, HZE), light grey – type of radiation not specified 4B show the distribution to the different kinds 
of EMF: dark grey – RF-EMF, middle grey – ELF-EMF, light grey – other). 90    Current Genomics, 2009, Vol. 10, No. 2  Blankenburg et al. 
tected effects have health consequences to biological sys-
tems or not. 
DISCUSSION 
  This literature survey focused its investigation on volume 
and distribution of omics technologies and their relevance 
for risk assessment of EMF in comparison to results in other 
areas. Although there is an accentuated role of EMF in the 
media [11] this is not reflected by the number of investiga-
tions using modern technologies. A prominent reason could 
be the lack of knowledge of a clear mode of action of low-
intensity EMF and especially of RF-EMF.  
  Omics technologies allow a fast and - with rising use – 
cost-effective screening of gene- and protein expression, 
characterization of new gene- and protein functions, the clas-
sification of genes, proteins and metabolites in pathways as 
well as the identification of therapeutic targets in the organ-
ism [12-14]. However, on closer inspection the majority of 
the investigated articles only used the omics vocabulary but 
could not fulfil their promises to use high-throughput omics 
 
 
 
 
 
 
 
 
 
 
Fig. (5). Number of publications per year. 
Graded grey shades mark the number of publications containing ionising radiation and EMF in the respective years. (dark grey – ionising 
radiation, light grey – EMF). 
 
 
 
 
 
 
 
 
 
 
 
Fig. (6). Number of publications per continent. 
The graphical representation shows the number of publications per continent. To relate the numbers of scientific articles respective to the 
countries the attribution of the articles to the countries took place by the first author of the publication. The two grey shades mark the consid-
ered ionising radiation and EMF, respectively (dark grey – ionising radiation, light grey – EMF). High-Throughput Omics Technologies  Current Genomics, 2009, Vol. 10, No. 2    91 
technologies. Published so far only expression analyses at 
the RNA level using chip arrays came into consideration. 
 
Table 1.  Investigated Biological Material: Cell Lines, Tissue 
of an Organ or Cell Structure are Summarized to 
One Notation 
Number of Publications 
Biological Material 
Ionising Radiation  EMF 
connective  tissue 12 4 
blood cells / ~vessels  24  16 
liver 2  1 
breast 5  6 
lymph 1  0 
nerves 3  7 
spleen 2  0 
cervix / ovar  6  0 
lung 2  0 
thyroid 4  0 
esophagus 3  0 
prostate 1  0 
skin 4  0 
brain 1  0 
eye 1  0 
tissues / cells of animals*  25  6 
plants 2  0 
bacteria 3  1 
yeast 6  1 
hybrid cells  2  0 
not specified  2  0 
 
  Currently numerous manufacturers of genechips, protein- 
and antibody arrays exist. Due to different hybridisation 
technologies of cDNA or oligonucleotides and proteins or 
antibodies fixed on carrier material [15-18] a direct compari-
son of results from applications of different manufacturers is 
very difficult. Nevertheless, cross-platform utilization of 
gene expression data could reduce the need for duplicate 
experiments and facilitate a more extensive exchange of data 
within the research community. Some measures for the cor-
respondence of the results from different gene expression 
platforms are already developed [19]. Meanwhile, platforms 
based on different technology principles reveal similar aber-
ration patterns, although unique amplification or deletion 
peaks at various locations could be detected by one of the 
platforms only [20]. 
  In our literature survey, self-made arrays and arrays from 
small manufacturers were used in more than half of all arti-
cles. A comparison or validation of the data would be very 
difficult because in most of the articles modern demands of 
state of the art experiments are not fulfilled. For instance, to 
ensure getting reliable data it is essential to perform repli-
cates and control experiments with alternative methods. Both 
prerequisites were practiced only in about half of the scien-
tific articles. 
  In comparison to research on ionising radiation it can be 
seen that in EMF research the usage of Affymetrix arrays has 
been nearly duplicated. This may be based on the fact that 
EMF research applying omics technologies started later than 
the research on ionising radiation. Most probably EMF re-
search benefited from the experience in the research on ion-
ising radiation. In addition, the different numbers of hybrid-
ized fragments on arrays of the different manufacturers 
and/or costs of the gene chips may have been accounted for a 
preference for one of the companies. 
  The effects of EMF have been examined since the 1970
th 
years [21, 22]. The increasing use of mobile phones and 
other wireless telecommunication devices in the last years 
required a worldwide network of fixed antenna or base sta-
tions. Hence, the result was an increased public interest to 
the induced health effects. This fact is supported by the ap-
pearance of the RF-EMF investigations from 1999 to 2007, 
using omics methods detected in our literature survey.  
  Approximately in the same time as the chip technology 
for omics investigations was developed in the 1990
th years 
[23] the World Health Organisation (WHO) created a project 
(the International Electromagnetic Fields Project) to investi-
gate health risks associated with technologies emitting EMF 
[24, 25]. In 2003 the WHO classified RF-EMF as an area of 
research with “high priority” and the European Commission 
launched the Coordination Action EMF-NET [26]. The re-
search was also financially supported by European projects 
such as “Risk evaluation of potential environmental hazards 
from low-energy electromagnetic field exposure using sensi-
tive  in vitro methods (REFLEX)” which included target-
oriented omics methods [27]. This was accompanied by a 
number of other international, European and national re-
search projects [28]. The intensive financial funding of this 
research in Europe is reflected in the increased number of 
scientific articles in EMF research using omics methods in 
comparison to publications of this research from Asia or 
America [29]. In 2006 a clear rise of publications in EMF 
research and investigations of ionising radiation with omics 
technologies is detected. Most of the projects run in the pe-
riod from 2000 to 2004 [30]. Therefore, the increase of the 
references in 2006 seems to be based on the finalization of 
these research activities. The following drop of articles in 
2007 might be due to less funding and that no clear effects of 
RF-EMF could be found. 
CONCLUDING REMARKS 
  With the help of omics technologies it is possible to in-
vestigate cellular states as well as biological correlations in 
cell lines, primary tissues and the whole organism. Omics 
technologies allow economical material usage, the simulta-
neous investigation of thousand of genes, proteins or me-92    Current Genomics, 2009, Vol. 10, No. 2  Blankenburg et al. 
tabolites and can be a capable tool to investigate effects of 
EMF. The data of our literature survey show a very hetero-
geneous distribution. Almost no material (cells or cell lines) 
was analysed twice by different groups. In addition, the vali-
dation of the omics experiments by other methods is absolute 
necessary. A sufficient number of replications in the same 
and in other labs are essential. Up to now in most of the in-
vestigations in EMF research using omics technologies this 
has not been done. Therefore, the data volume of the sepa-
rate experiments with diverse biological material is not suffi-
cient to give clear scientific statements. 
ACKNOWLEDGEMENT 
  This work was supported by the Helmholtz-Association 
(grant SO-033). 
REFERENCES 
[1]  Gomase, V.S., Tagore, S. Toxicogenomics. Curr. Drug Metab. 
2008, 9(3): 250-254. 
[2]  Ellis, D.I., Dunn, W.B., Griffin, J.L., Allwood, J.W., Goodacre, R. 
Metabolic fingerprinting as a diagnostic tool. Pharmacogenomics 
2007, 8(9): 1243-1266. 
[3]  Guidelines for limiting exposure to time-varying electric, magnetic, 
and electromagnetic fields (up to 300 GHz). International Commis-
sion on Non-Ionizing Radiation Protection. Health Phys.  1998, 
74(4): 494-522. 
[4]  Saunders, R.D., Jefferys, J.G. A neurobiological basis for ELF 
guidelines. Health Phys. 2007, 92(6): 596-603. 
[5]  Challis, L.J. Mechanisms for interaction between RF fields and 
biological tissue. Bioelectromagnetics 2005, 7: S98-S106. 
[6]*  D’Andrea, J.A., Ziriax, J.M., Adair, E.R. Radio frequency electro-
magnetic fields: mild hyperthermia and safety standards. Prog. 
Brain Res. 2007, 162: 107-135.  
  The article is a review of the literature that serves as the basis for 
safety exposure recommendations by the International Commission 
on Non-Ionizing Radiation Protection, 1998 (ICNIRP) and the 
IEEE Standards for safety levels with respect to human exposure to 
Radio Frequency Electromagnetic Fields (RF-EMF) in the range of 
3 kHz to 300 GHz (IEEE C95.1).  
[7] http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed 
[8] http://www.emf-portal.org/_index.php?l=e 
[9] http://www.epa.gov/lawsregs/laws/tsca.html 
[10]  Foth, H., Hayes, A. Concept of REACH and impact on evaluation 
of chemicals. Hum. Exp. Toxicol. 2008, 27(1): 5-21. 
[11]  Elvers, H.-D., Jandrig, B., Grummich, K., Tannert, C. Mobile 
phones and health: Media coverage study of German newspapers 
on possible adverse health effects of mobile phone use. Health Risk 
Soc. 2009, 11(1): (In press). 
[12]  Aguilar-Mahecha, A., Hassan, S., Ferrario, C., Basik, M. Microar-
rays as validation strategies in clinical samples: tissue and protein 
microarrays. OMICS 2006, 10(3): 311-326. 
[13]  Kurella, M., Hsiao, L.-L., Yoshishida, T., Randall, J.D., Chow, G., 
Sarang, S.S. Jensen, R.V., Gullans, S. DNA Microarray Analysis of 
Complex Biologic Processes. J. Am. Soc. Nephrol. 2001, 12: 1072-
1078. 
[14]  Cuperlovic-Culf, M., Belacel, N., Culf, A.S., Ouellette, R.J. Mi-
croarray analysis of alternative splicing. OMICS 2006, 10(3): 344-
357. 
[15]  Cullen, P., Lorkowski, S. DNA microarrays in medicine: manufac-
turing techniques and potential applications. Expert Opin. Ther. 
Patents 2002, 12(12): 1783-1794. 
[16]  Jenkins, R.E., Pennington, S.R. Arrays for protein expression pro-
filing: towards a viable alternative to two-dimensional gel electro-
phoresis? Proteomics 2001, 1(1): 13-29.  
[17]  Nath, N., Hurst, R., Hook, B., Meisenheimer, P., Zhao, K.Q., Nas-
sif, N., Bulleit, R.F., Storts, D.R. Improving protein array perform-
ance: Focus on washing and storage conditions. J. Proteome Res. 
2008, 7(10): 4475-4482. 
[18]  áik, R., Woelk, C.H., Corbeil, J. Microarray truths and conse-
quences. J. Mol. Endocrinol. 2004, 33(1): 1-9.  
[19]  van Ruissen, F., Schaaf, G.J., Kool, M., Baas, F., Ruijter, J.M. 
Scaling of gene expression data allowing the comparison of differ-
ent gene expression platforms. Methods Mol. Biol. 2008, 387: 169-
183. 
[20]  Baumbusch, L.O., Aarøe, J., Johansen, F.E., Hicks, J., Sun, H., 
Bruhn, L., Gunderson, K., Naume, B., Kristensen, V.N., Liestøl, 
K., Børresen-Dale, A.L., Lingjaerde, O.C. Comparison of the Ag-
ilent, ROMA/NimbleGen and Illumina platforms for classification 
of copy number alterations in human breast tumors. BMC Genom-
ics 2008, 9: 379. 
[21]  Krueger, A.P., Reed, E.J. A study of the biological effects of cer-
tain ELF electromagnetic fields. Int. J. Biometeorol. 1975, 19(3): 
194-201. javascript:PopUpMenu2_Set(Menu1232065); 
[22] http://www.who.int/mediacentre/factsheets/fs322/en/index.html 
[23]  Fodor, S.P., Rava, R.P., Huang, X.C., Pease, A.C., Holmes, C.P., 
Adams, C.L. Multiplexed biochemical assays with biological chips. 
Nature 1993, 364: 555-556. 
[24] http://www.who.int/mediacentre/factsheets/fs322/en/index.html   
[25] http://www.who.int/mediacentre/factsheets/fs193/en/ 
[26]**  Ravazzani, P. The interpretation of the results of the research on 
electromagnetic fields and health in Europe: the EC Coordination 
Action EMF-NET. Ann. Telecommun. 2008, 63: 11-15. 
  The article reflects a bright overview of the EC coordination action 
EMF-NET established by the European Commission in 2004. It 
summarizes the main objectives, introduces the coordinators, com-
prises separate projects and aims and shows further outcomes. 
[27] http://ec.europa.eu/research/environment/pdf/env_health_projects/ 
electromagnetic_fields/e-reflex.pdf 
[28] http://web.jrc.ec.europa.eu/emf-net/doc/Reports/Report%20on%20 
European%20EMF%20plans%20Aug2006.pdf 
[29] http://www.emf-forschungsprogramm.de/abschlussphase/DMF_ 
FinalConference_June2008_VanDeventer_ResearchAgenda.pdf 
[30] http://web.jrc.ec.europa.eu/emf-net/emfprojects.cfm?prjtype=2 
 
 
 
 
 